Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…
Mankind Pharma
Read More
India’s Pharma Exports Face High Risk Amid US Tariff
India’s pharmaceutical sector is staring at heightened uncertainty following US President Donald Trump’s recent increased tariff on Indian goods. On…
Mankind Pharma and Innovent Collaborate to Improve Cancer Care Access in India
Mankind Pharma has announced a strategic partnership with Innovent Biologics to introduce Sintilimab, a PD-1 immunotherapy, to the Indian market….
2024 IPO Boom: India’s Healthcare and Pharma Sectors Secure ₹14,811 Crore – A Five-Year High In 2024
Credit:- Sugandh Khandelwal India’s healthcare and pharmaceutical sectors raised ₹14,811 crore through initial public offerings (IPOs), marking the highest annual…